Skip to main content

NYSE:CC - The Chemours Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $30.75
  • Forecasted Upside: -11.20 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$34.63
▼ -0.02 (-0.06%)
1 month | 3 months | 12 months
Get New The Chemours Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$30.75
▼ -11.20% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for The Chemours in the last 3 months. The average price target is $30.75, with a high forecast of $40.00 and a low forecast of $15.00. The average price target represents a -11.20% upside from the last price of $34.63.

Buy

The current consensus among 8 contributing investment analysts is to buy stock in The Chemours. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings
11/16/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
2/14/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
5/14/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 0 sell ratings
8/12/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
11/10/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings
2/8/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/9/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/9/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021ArgusUpgradeHold ➝ Buy$40.00High
i
2/17/2021CitigroupBoost Price Target$27.00 ➝ $29.00Low
i
2/16/2021BMO Capital MarketsBoost Price Target$33.00 ➝ $38.00Low
i
2/16/2021Morgan StanleyBoost Price TargetEqual Weight$28.00 ➝ $30.00Low
i
1/8/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$27.00 ➝ $35.00High
i
12/14/2020Morgan StanleyBoost Price TargetEqual Weight$23.00 ➝ $28.00Medium
i
12/4/2020BarclaysDowngradeOverweight ➝ Equal Weight$26.00 ➝ $28.00Medium
i
11/30/2020Alembic Global AdvisorsInitiated CoverageOverweight$31.00High
i
11/16/2020Morgan StanleyBoost Price TargetEqual Weight$12.00 ➝ $23.00High
i
11/5/2020BMO Capital MarketsBoost Price TargetOutperform$26.00 ➝ $28.00High
i
11/5/2020BarclaysBoost Price TargetOverweight$22.00 ➝ $26.00High
i
8/4/2020CitigroupBoost Price TargetNeutral$16.00 ➝ $18.00Low
i
8/3/2020Royal Bank of CanadaBoost Price TargetSector Perform$15.00 ➝ $19.00High
i
8/3/2020BarclaysBoost Price TargetOverweight$16.00 ➝ $22.00High
i
7/9/2020UBS GroupBoost Price TargetNeutral$12.00 ➝ $15.00Medium
i
5/8/2020UBS GroupBoost Price TargetNeutral$9.00 ➝ $12.00Medium
i
5/7/2020SunTrust BanksBoost Price TargetHold$10.00 ➝ $12.00Low
i
4/14/2020Susquehanna BancsharesLower Price Target$23.00 ➝ $17.00High
i
4/9/2020CitigroupLower Price TargetNeutral$10.00 ➝ $8.00High
i
4/3/2020CfraLower Price TargetStrong-Buy ➝ Hold$21.00 ➝ $11.00Low
i
4/1/2020Royal Bank of CanadaLower Price TargetSector Perform$13.00 ➝ $11.00High
i
3/30/2020Morgan StanleyLower Price TargetEqual Weight$15.00 ➝ $12.00Medium
i
3/26/2020Royal Bank of CanadaReiterated RatingHold$13.00Medium
i
3/26/2020BMO Capital MarketsLower Price TargetOutperform$33.00 ➝ $21.00Low
i
3/25/2020SunTrust BanksLower Price TargetHold$19.00 ➝ $10.00High
i
3/23/2020Jefferies Financial GroupDowngradeBuy ➝ HoldHigh
i
2/19/2020Royal Bank of CanadaReiterated RatingHold$20.00Low
i
2/18/2020SunTrust BanksBoost Price TargetHold$17.00 ➝ $19.00Medium
i
2/14/2020CfraUpgradeBuy ➝ Strong-BuyHigh
i
12/22/2019Royal Bank of CanadaReiterated RatingHold$19.00Medium
i
12/20/2019JPMorgan Chase & Co.Lower Price TargetNeutral$21.00 ➝ $19.00High
i
11/6/2019CfraUpgradeHold ➝ BuyMedium
i
11/6/2019SunTrust BanksBoost Price TargetIn-Line ➝ Hold$20.00Medium
i
10/2/2019UBS GroupLower Price TargetNeutral$19.00 ➝ $14.50Low
i
9/9/2019BMO Capital MarketsLower Price TargetOutperform$31.00 ➝ $23.00High
i
Rating by John McNulty at BMO Capital Markets
8/20/2019Susquehanna BancsharesUpgradeNeutral ➝ Positive$37.00 ➝ $18.00Medium
i
8/9/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$32.00 ➝ $16.00High
i
8/6/2019ArgusDowngradeBuy ➝ HoldMedium
i
8/5/2019SunTrust BanksDowngradeBuy ➝ HoldHigh
i
8/5/2019BMO Capital MarketsLower Price TargetOutperform$45.00 ➝ $31.00High
i
Rating by John McNulty at BMO Capital Markets
7/12/2019CitigroupDowngradeBuy ➝ Neutral$40.00 ➝ $20.00High
i
7/9/2019SunTrust BanksReiterated RatingBuyLow
i
6/24/2019BMO Capital MarketsSet Price TargetBuy$50.00 ➝ $45.00Low
i
Rating by John McNulty at BMO Capital Markets
6/19/2019Morgan StanleySet Price TargetHold$26.00High
i
Rating by Vincent Andrews at Morgan Stanley
6/10/2019Jefferies Financial GroupLower Price TargetBuy$48.00 ➝ $30.00Medium
i
6/3/2019BarclaysReiterated RatingBuy$42.00High
i
5/6/2019Royal Bank of CanadaLower Price TargetOutperform$43.00High
i
5/6/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$40.00 ➝ $34.00High
i
4/15/2019SunTrust BanksUpgradeHold ➝ Buy$40.00 ➝ $52.00High
i
2/20/2019CitigroupReiterated RatingBuy$43.00Medium
i
2/19/2019SunTrust BanksBoost Price TargetHold$40.00High
i
2/19/2019Susquehanna BancsharesReiterated RatingPositive ➝ Neutral$37.00Low
i
1/15/2019BarclaysReiterated RatingBuy$48.00Medium
i
1/8/2019HSBCInitiated CoverageBuy ➝ Buy$52.00Medium
i
1/4/2019CitigroupUpgradeNeutral ➝ BuyHigh
i
11/5/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$68.00 ➝ $58.00Low
i
Rating by John McNulty at BMO Capital Markets
11/5/2018Susquehanna BancsharesLower Price TargetPositive$65.00 ➝ $44.00Low
i
11/5/2018SunTrust BanksLower Price TargetHold$38.00Medium
i
11/2/2018CitigroupDowngradeBuy ➝ Neutral$44.00 ➝ $38.00High
i
10/11/2018CitigroupLower Price TargetBuy$61.00 ➝ $44.00High
i
9/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$48.00 ➝ $47.00Low
i
Rating by Vincent Andrews at Morgan Stanley
9/13/2018Royal Bank of CanadaReiterated RatingOutperformLow
i
8/7/2018BarclaysReiterated RatingBuy$62.00Medium
i
8/6/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$70.00 ➝ $68.00Low
i
7/31/2018SunTrust BanksInitiated CoverageHold$51.00Medium
i
7/18/2018Royal Bank of CanadaInitiated CoverageOutperform$60.00High
i
7/17/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$57.50 ➝ $48.00High
i
Rating by Vincent Andrews at Morgan Stanley
7/11/2018CitigroupLower Price TargetBuy ➝ Buy$69.00 ➝ $64.00High
i
5/21/2018Vertical ResearchInitiated CoverageBuyLow
i
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$66.00 ➝ $69.00Low
i
5/8/2018BarclaysReiterated RatingBuy$64.00Low
i
4/10/2018CitigroupLower Price TargetBuy ➝ Buy$68.00 ➝ $66.00Low
i
3/27/2018BMO Capital MarketsInitiated CoverageOutperform$68.00Medium
i
1/30/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.50Medium
i
12/6/2017BarclaysReiterated RatingBuy$60.00Low
i
12/6/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00Medium
i
12/4/2017Jefferies Financial GroupBoost Price TargetBuy$66.00High
i
11/6/2017BarclaysBoost Price TargetOverweight$55.00 ➝ $58.00N/A
i
11/3/2017UBS GroupBoost Price TargetNeutral$50.00 ➝ $59.00N/A
i
8/10/2017ArgusReiterated RatingBuy$50.00 ➝ $55.00High
i
8/7/2017UBS GroupUpgradeSell ➝ Neutral$36.00 ➝ $50.00Low
i
8/4/2017JPMorgan Chase & Co.Boost Price TargetOverweight$55.00Low
i
8/4/2017CitigroupBoost Price TargetBuy$45.00 ➝ $59.00High
i
8/3/2017Jefferies Financial GroupBoost Price TargetBuy$60.00High
i
7/13/2017Jefferies Financial GroupReiterated RatingBuy$48.00 ➝ $50.00Medium
i
7/5/2017CitigroupUpgradeNeutral ➝ Buy$43.00 ➝ $45.00Low
i
6/16/2017Jefferies Financial GroupReiterated RatingBuy$48.00Low
i
6/14/2017UBS GroupReiterated RatingSell$35.00 ➝ $36.00N/A
i
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 ➝ $55.00Low
i
5/12/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$39.00 ➝ $50.00High
i
4/17/2017CitigroupBoost Price TargetBuy$62.00 ➝ $63.00Medium
i
4/14/2017CitigroupReiterated RatingNeutral$34.00 ➝ $40.00N/A
i
3/29/2017Jefferies Financial GroupUpgradeHold ➝ Buy$35.00 ➝ $48.00Medium
i
2/17/2017Susquehanna BancsharesUpgradeNeutral ➝ Positive$40.00N/A
i
2/17/2017CitigroupUpgradeNeutral ➝ Positive$26.00 ➝ $40.00N/A
i
2/17/2017UBS GroupUpgradeNeutral ➝ PositiveN/A
i
2/15/2017Jefferies Financial GroupBoost Price TargetHold$25.00 ➝ $35.00N/A
i
2/13/2017The Goldman Sachs GroupUpgradeNeutral ➝ BuyN/A
i
12/12/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$23.00 ➝ $27.00N/A
i
11/16/2016Jefferies Financial GroupBoost Price TargetHold$17.00 ➝ $25.00N/A
i
Rating by Laurence Alexander at Jefferies Financial Group Inc.
11/10/2016Jefferies Financial GroupReiterated RatingHold$15.00 ➝ $17.00N/A
i
Rating by Laurence Alexander at Jefferies Financial Group Inc.
9/1/2016Jefferies Financial GroupBoost Price TargetHold$10.00 ➝ $15.00N/A
i
Rating by Laurence Alexander at Jefferies Financial Group Inc.
8/11/2016CitigroupLower Price TargetNeutral$11.00 ➝ $9.00N/A
i
Rating by PJ Juvekar at Citigroup Inc.
8/10/2016ArgusUpgradeHold ➝ Buy$13.00N/A
i
Rating by David Coleman at Argus
8/9/2016UBS GroupBoost Price TargetSell$5.00 ➝ $5.25N/A
i
7/15/2016CitigroupReiterated RatingNeutral$10.50 ➝ $9.00N/A
i
6/15/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
Rating by Laurence Alexander at Jefferies Financial Group Inc.
5/13/2016ArgusReiterated RatingHoldN/A
i
5/9/2016BarclaysBoost Price TargetOverweight$14.00 ➝ $15.00N/A
i
Rating by Duffy Fischer at Barclays PLC
(Data available from 5/9/2016 forward)
The Chemours logo
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $34.63
$34.26
$35.25

50 Day Range

MA: $28.96
$24.85
$34.65

52 Week Range

Now: $34.63
$10.62
$35.25

Volume

903,834 shs

Average Volume

1,451,262 shs

Market Capitalization

$5.72 billion

P/E Ratio

N/A

Dividend Yield

2.89%

Beta

2.3

Frequently Asked Questions

What sell-side analysts currently cover shares of The Chemours?

The following sell-side analysts have issued stock ratings on The Chemours in the last twelve months: Alembic Global Advisors, Argus, Barclays PLC, BMO Capital Markets, Citigroup Inc., Morgan Stanley, Royal Bank of Canada, TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for CC.

What is the current price target for The Chemours?

8 Wall Street analysts have set twelve-month price targets for The Chemours in the last year. Their average twelve-month price target is $30.75, suggesting a possible downside of 11.2%. Argus has the highest price target set, predicting CC will reach $40.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $15.00 for The Chemours in the next year.
View the latest price targets for CC.

What is the current consensus analyst rating for The Chemours?

The Chemours currently has 4 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CC will outperform the market and that investors should add to their positions of The Chemours.
View the latest ratings for CC.

What other companies compete with The Chemours?

How do I contact The Chemours' investor relations team?

The Chemours' physical mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company's listed phone number is 302-773-1000 and its investor relations email address is [email protected] The official website for The Chemours is www.chemours.com.